S. Loukides (Athens, Greece), P. Montuschi (Rome, Italy), G. Carpagnano (Foggia, Italy), Z. Lazar (Budapest, Hungary)
LATE-BREAKING ABSTRACT: A simple practical method to partition lung peripheral and airway nitric oxide
P. Paredi, S. A. Kharitonov, P. J. Barnes, O. Usmani (London, United Kingdom)
|  |
Endogenous and exogenous metabolites in exhaled breath condensate in asthma
E.K. Anaev, T.N. Anokhina, I.A. Revelsky, A.A. Rodionov, A.I. Revelsky, A.G. Chuchalin (Moscow, Russian Federation)
| |
Exercise increases the hydrogen peroxide release in exhaled breath condensate
E.M. Marek, J. Volke, W. Marek, P. Platen (Bochum, Germany)
| |
Protein markers in the exhaled breath condensate of lung carcinoma patients
G. Kireeva, A. Ryabokon, A. Kononikhin, V. Bagrov, E. Anaev, O. Pikin, I. Popov, E. Nikolaev, S. Varfolomeev (Moscow, Russian Federation)
| |
Particle content in exhaled air depending on breathing maneuver
P. Larsson, B. Bake, E. Mirgorodskaya, A.C. Almstrand, A. Bredberg, A.C. Olin (Gothenburg, Sweden)
|  |
Exhaled breath temperature in COPD patients
G. Garcia, M. Bergna, O. Lopez Jové (La Plata, Vicente Lopez, Argentina)
| |
Concentrations of nitric oxide metabolites in the exhaled breath condensate in children with different bronchial asthma control
S. Soodaeva, I. Klimanov, T. Eliseeva, N. Kubysheva (Moscow, Nizhny Novgorod, Russian Federation)
| |
Saturated fatty acids in exhaled breath condensate in COPD patients
T.N. Anokhina, E.K. Anaev, A.I. Revelsky, I.A. Revelsky, A.G. Chuchalin (Moscow, Russian Federation)
| |
Spontaneous airway obstruction masks FeNO level in patients with asthma but not COPD
H. Zhao, R. Li, Z. Liang, S. Cai (Guangzhou, China)
| |
No difference between measured and calculated FENO0.05 with the clinical software for extended NO analysis
A. Thornadtsson, P. Meriläinen, M. Högman (Gävle, Uppsala, Sweden)
| |
FeNO measurements in pregnant asthmatic women
B. Panaszek, M. Nittner-Marszalska, A. Dor-Wojnarowska, H. Marszalska, R. Pawlowicz, M. Kraus-Filarska (Wroclaw, Poland)
| |
Investigation on the effectiveness of the Mostgraph and fractional exhaled nitric oxide measurement in chronic cough
C. Nakano, N. Hatanaka, T. Yamagishi, H. Kamemura, N. Kodaka, A. Miura, A. Kitahara, Y. Kurose, K. Sugawa, K. Kashiwa, Y. Kamata, H. Hayashi, M. Toyoda, K. Hirayama, K. Sanno (Tokyo, Japan)
| |
FeNO (fractional exhaled nitric oxide) measurements in pregnant asthmatic women. The long-term, intra-subject variability of FeNO in controlled asthma
B. Panaszek, A. Dor-Wojnarowska, M. Nittner-Marszalska, R. Pawlowicz, H. Marszalska, A. Kazimerczak (Wroclaw, Poland)
| |
No effect of breathing dry gas on exhaled nitric oxide concentration at rest
I.S. Grønningsæter, S. Hoel, E. Thorsen (Bergen, Norway)
| |
Fractional exhaled nitric oxide in bronchiectasis
Y.J. Cho, H.J. Lim, J.S. Park, S.W. Lee, J.H. Lee, C.T. Lee, H.I. Yoon (Seongnam, Republic Of Korea)
| |
The usefulness of the simultaneous measurement of IOS and FeNO in the management of asthma
S. Hozawa, M. Terada, M. Hozawa (Hiroshima, Japan)
| |
Asthma control test (ACT), fractionated exhaled nitric oxide (FeNO) and forced expiratory volume in 1 second (FEV1) correlation in asthma control
F. Yangui, M. Abouda, M. Triki, N. Balloumi, A. Migaou, H. Khouani, M.R. Charfi (La Marsa, Tunisia)
| |
Standardization procedures for in-vitro measurements using differential ion mobility spectrometry (DMS)
R. Purkhart, R. Graupner, G. Becher (Geyer, Bernau, Germany)
| |
Volatile organic compounds may provide a new and promising tool for diagnosing interstitial lung diseases
A. Boots, R. Schins, R. Godschalk, C. Albrecht, J. Dallinga, A. Bast, F. Schleich, M. Drent, F. J. van Schooten (Maastricht, Netherlands; Düsseldorf, Germany)
| |
Speech breathing pattern analysis in adults with a self reported history of asthma
R. Tehrany, A. Bruton, A. Barney (Southampton, United Kingdom)
| |